The Principal Investigator of the program is Dr. Emma Fernández-Repollet. She is Professor in the Department of Pharmacology of the School of Medicine. Dr. Fernández-Repollet occupied the position of Associate Program Director from 1986-1993 and the position of Program Director from 1993-2011.
As Principal Investigator, Dr. Fernández-Repollet oversees the entire Program and has all responsibilities for day-to-day operations ensuring that programmatic goals are met and that appropriate institutional support is provided to the Program. The PI also ensures that the interests of the RCMI Program are taken into account during formulation/revision of policy, both on the Campus and at the level of the University of Puerto Rico Presidency and Central Administration. The experience of Dr. Fernández-Repollet as Vice President for Research and Technology of the University of Puerto Rico system and member of the National Advisory Research Resources Council has proved helpful in addressing these responsibilities. Dr. Fernández-Repollet chairs the Steering Committee of the RCMI Translational Research Network (RTRN).
Dr. Wilfredo E. De Jesus-Monge is a physician scientist with education, training, experience, and interest in cancer clinical and disparities research. He has occupied multiple leadership positions in clinical research and is a member of science and health organizations in PR and US. He has advised faculty members and students in all development stages of clinical research, taught courses in science, health, and research at the undergraduate and graduate levels, and has moderated and judged research abstracts / presentations at biomedical scientific meetings in PR, US, and online. Dr. De Jesus-Monge has received multiple scholarships and awards for his accomplishments, including the 2014 RCMI Translational Research Network Scholar of Health Disparities Award, the 2012 Genetic Engineering & Biotechnology News TEN Award for Innovative Research, the 2007-2015 Physician’s Recognition Award from the American Medical Association, the 2008 Minority Scholar in Cancer Research Award from the American Association for Cancer Research, and the 2014-2015 Scientific Author Award for scientific productivity from the Universidad del Turabo. He has published his work in 18 articles, 5 chapters, and has presented his findings in many events in PR, US, and Spain.
Dr. De Jesus-Monge obtained a BS (Biology, 1999) from the University of Puerto Rico (UPR)-Rio Piedras Campus, a MD (Medicine, with Research Pathway, 2004) degree from the UPR School of Medicine, a Postdoctoral MSc (Clinical Research, 2007) degree from the UPR-Medical Sciences Campus, and a Postdoctoral Research Fellowship in Cancer Biology (2012) from the University of Massachusetts Medical School.
Phone: 787.758.2525 ext. 7033